vs
AETHLON MEDICAL INC（AEMD）与iRhythm Holdings, Inc.（IRTC）财务数据对比。点击上方公司名可切换其他公司
iRhythm Holdings, Inc.的季度营收约是AETHLON MEDICAL INC的3483.6倍（$208.9M vs $60.0K）。iRhythm Holdings, Inc.净利率更高（2.7% vs -2926.4%，领先2929.1%）。iRhythm Holdings, Inc.自由现金流更多（$14.5M vs $-2.0M）
AETHLON MEDICAL INC是一家临床阶段医疗科技企业，专注开发针对性治疗类医疗器械，核心产品血液净化器可从血液中去除有害病毒、肿瘤外泌体及其他病原体，业务聚焦传染病和肿瘤治疗赛道，主要市场覆盖北美地区。
iRhythm Holdings是一家专注于心脏护理领域的数字医疗企业，开发可穿戴动态心脏监测设备及配套AI分析工具，主要服务美国市场的医疗机构与患者，帮助检测房颤等心律异常病症，为临床诊断提供可靠的数据支持。
AEMD vs IRTC — 直观对比
营收规模更大
IRTC
是对方的3483.6倍
$60.0K
净利率更高
IRTC
高出2929.1%
-2926.4%
自由现金流更多
IRTC
多$16.5M
$-2.0M
损益表 — Q3 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $60.0K | $208.9M |
| 净利润 | $-1.8M | $5.6M |
| 毛利率 | — | 70.9% |
| 营业利润率 | -3026.4% | 1.1% |
| 净利率 | -2926.4% | 2.7% |
| 营收同比 | — | 27.1% |
| 净利润同比 | 49.4% | 518.5% |
| 每股收益（稀释后） | $-10.05 | $0.18 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AEMDIRTC
| Q4 25 | — | $208.9M | ||
| Q3 25 | — | $192.9M | ||
| Q2 25 | — | $186.7M | ||
| Q1 25 | — | $158.7M | ||
| Q4 24 | $60.0K | $164.3M | ||
| Q3 24 | $95.1K | $147.5M | ||
| Q2 24 | — | $148.0M | ||
| Q1 24 | — | $131.9M |
净利润AEMDIRTC
| Q4 25 | — | $5.6M | ||
| Q3 25 | — | $-5.2M | ||
| Q2 25 | — | $-14.2M | ||
| Q1 25 | — | $-30.7M | ||
| Q4 24 | $-1.8M | $-1.3M | ||
| Q3 24 | $-2.8M | $-46.2M | ||
| Q2 24 | — | $-20.1M | ||
| Q1 24 | — | $-45.7M |
毛利率AEMDIRTC
| Q4 25 | — | 70.9% | ||
| Q3 25 | — | 71.1% | ||
| Q2 25 | — | 71.2% | ||
| Q1 25 | — | 68.8% | ||
| Q4 24 | — | 70.0% | ||
| Q3 24 | — | 68.8% | ||
| Q2 24 | — | 69.9% | ||
| Q1 24 | — | 66.3% |
营业利润率AEMDIRTC
| Q4 25 | — | 1.1% | ||
| Q3 25 | — | -4.4% | ||
| Q2 25 | — | -10.0% | ||
| Q1 25 | — | -20.5% | ||
| Q4 24 | -3026.4% | -2.5% | ||
| Q3 24 | -3050.2% | -34.1% | ||
| Q2 24 | — | -15.5% | ||
| Q1 24 | — | -28.9% |
净利率AEMDIRTC
| Q4 25 | — | 2.7% | ||
| Q3 25 | — | -2.7% | ||
| Q2 25 | — | -7.6% | ||
| Q1 25 | — | -19.3% | ||
| Q4 24 | -2926.4% | -0.8% | ||
| Q3 24 | -2950.2% | -31.3% | ||
| Q2 24 | — | -13.6% | ||
| Q1 24 | — | -34.6% |
每股收益（稀释后）AEMDIRTC
| Q4 25 | — | $0.18 | ||
| Q3 25 | — | $-0.16 | ||
| Q2 25 | — | $-0.44 | ||
| Q1 25 | — | $-0.97 | ||
| Q4 24 | $-10.05 | $-0.03 | ||
| Q3 24 | $-16.11 | $-1.48 | ||
| Q2 24 | — | $-0.65 | ||
| Q1 24 | — | $-1.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.8M | $583.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $4.3M | $152.7M |
| 总资产 | $6.5M | $1.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AEMDIRTC
| Q4 25 | — | $583.8M | ||
| Q3 25 | — | $565.2M | ||
| Q2 25 | — | $545.5M | ||
| Q1 25 | — | $520.6M | ||
| Q4 24 | $4.8M | $535.6M | ||
| Q3 24 | $6.9M | $522.0M | ||
| Q2 24 | — | $561.5M | ||
| Q1 24 | — | $569.1M |
股东权益AEMDIRTC
| Q4 25 | — | $152.7M | ||
| Q3 25 | — | $121.9M | ||
| Q2 25 | — | $103.7M | ||
| Q1 25 | — | $86.7M | ||
| Q4 24 | $4.3M | $90.9M | ||
| Q3 24 | $6.0M | $71.8M | ||
| Q2 24 | — | $99.2M | ||
| Q1 24 | — | $90.3M |
总资产AEMDIRTC
| Q4 25 | — | $1.0B | ||
| Q3 25 | — | $995.2M | ||
| Q2 25 | — | $964.0M | ||
| Q1 25 | — | $926.1M | ||
| Q4 24 | $6.5M | $931.4M | ||
| Q3 24 | $8.8M | $909.7M | ||
| Q2 24 | — | $919.2M | ||
| Q1 24 | — | $909.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.0M | $26.2M |
| 自由现金流经营现金流 - 资本支出 | $-2.0M | $14.5M |
| 自由现金流率自由现金流/营收 | -3357.0% | 6.9% |
| 资本支出强度资本支出/营收 | 3.7% | 5.6% |
| 现金转化率经营现金流/净利润 | — | 4.70× |
| 过去12个月自由现金流最近4个季度 | — | $34.5M |
8季度趋势，按日历期对齐
经营现金流AEMDIRTC
| Q4 25 | — | $26.2M | ||
| Q3 25 | — | $34.9M | ||
| Q2 25 | — | $27.7M | ||
| Q1 25 | — | $-7.9M | ||
| Q4 24 | $-2.0M | $19.2M | ||
| Q3 24 | $-2.2M | $24.3M | ||
| Q2 24 | — | $11.8M | ||
| Q1 24 | — | $-52.0M |
自由现金流AEMDIRTC
| Q4 25 | — | $14.5M | ||
| Q3 25 | — | $20.1M | ||
| Q2 25 | — | $17.3M | ||
| Q1 25 | — | $-17.3M | ||
| Q4 24 | $-2.0M | $12.4M | ||
| Q3 24 | — | $15.5M | ||
| Q2 24 | — | $3.4M | ||
| Q1 24 | — | $-61.8M |
自由现金流率AEMDIRTC
| Q4 25 | — | 6.9% | ||
| Q3 25 | — | 10.4% | ||
| Q2 25 | — | 9.3% | ||
| Q1 25 | — | -10.9% | ||
| Q4 24 | -3357.0% | 7.5% | ||
| Q3 24 | — | 10.5% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | -46.8% |
资本支出强度AEMDIRTC
| Q4 25 | — | 5.6% | ||
| Q3 25 | — | 7.7% | ||
| Q2 25 | — | 5.6% | ||
| Q1 25 | — | 5.9% | ||
| Q4 24 | 3.7% | 4.2% | ||
| Q3 24 | 0.0% | 6.0% | ||
| Q2 24 | — | 5.7% | ||
| Q1 24 | — | 7.4% |
现金转化率AEMDIRTC
| Q4 25 | — | 4.70× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AEMD
暂无分部数据
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
